Charles River Laboratories International (CRL) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $85.2 million.
- Charles River Laboratories International's Accumulated Depreciation & Amortization fell 344.0% to $85.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.2 million, marking a year-over-year decrease of 344.0%. This contributed to the annual value of $361.7 million for FY2024, which is 1515.87% up from last year.
- Charles River Laboratories International's Accumulated Depreciation & Amortization amounted to $85.2 million in Q3 2025, which was down 344.0% from $119.5 million recorded in Q2 2025.
- In the past 5 years, Charles River Laboratories International's Accumulated Depreciation & Amortization registered a high of $361.7 million during Q4 2024, and its lowest value of $85.2 million during Q3 2025.
- Over the past 5 years, Charles River Laboratories International's median Accumulated Depreciation & Amortization value was $119.9 million (recorded in 2025), while the average stood at $183.0 million.
- Examining YoY changes over the last 5 years, Charles River Laboratories International's Accumulated Depreciation & Amortization showed a top increase of 4101.25% in 2025 and a maximum decrease of 344.0% in 2025.
- Quarter analysis of 5 years shows Charles River Laboratories International's Accumulated Depreciation & Amortization stood at $265.5 million in 2021, then rose by 14.43% to $303.9 million in 2022, then grew by 3.37% to $314.1 million in 2023, then grew by 15.16% to $361.7 million in 2024, then crashed by 76.46% to $85.2 million in 2025.
- Its Accumulated Depreciation & Amortization was $85.2 million in Q3 2025, compared to $119.5 million in Q2 2025 and $120.4 million in Q1 2025.